Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3 (BioSput-Air)
Sponsor: Universitaire Ziekenhuizen KU Leuven
Terminated
A lot of patients recruited in our center were already on montelukast treatment. It was not possible to recruit sufficient patients for the study.
Other terminated trials from Universitaire Ziekenhuizen KU Leuven
- Ulcerative Colitis · Phase PHASE2/PHASE3 · Oct 2025
- Tibial Plateau Fracture · Dec 2024
- Hepcidin · Dec 2023
- Ovarian Cancer · Phase PHASE2 · Oct 2023
- Compress Compliant Pre-Stress System · Phase NA · Aug 2023
See all terminations from Universitaire Ziekenhuizen KU Leuven
A NA clinical study on Asthmatic Patients, this trial is terminated or withdrawn. The trial is conducted by Universitaire Ziekenhuizen KU Leuven and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Nov 2022 — Jul 2024 [monthly]
Terminated NA
-
Dec 2021 — Nov 2022 [monthly]
Terminated NA
-
Jan 2021 — Dec 2021 [monthly]
Terminated NA
▶ Show 5 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated NA
-
Jun 2018 — Nov 2020 [monthly]
Terminated NA
-
May 2018 — Jun 2018 [monthly]
Terminated NA
-
Aug 2017 — May 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Universitaire Ziekenhuizen KU Leuven
For direct contact, visit the study record on ClinicalTrials.gov .